OrthoPediatrics reports record FY2024 revenue of $204.7M (+38% YoY), issues 2025 guidance

ORTHOPEDIATRICS CORP

2024-FY EPS reported -$1.64 revenue$204,727,000

Preliminary unaudited FY2024 revenue $204.7M, up 38% from $148.7M in 2023.
Q4 2024 revenue $52.7M (+40% YoY); domestic Q4 $42.9M (+52%), international $9.8M (+5%).
2025 revenue guidance $235-242M (15-18% growth); adjusted EBITDA $15-17M.
Over 34,000 children helped in Q4; cumulative >1.1 million since inception.
Annual set deployment ~$15M in 2025; full results due in early March.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.